{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:08:09Z","timestamp":1767474489514},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12185-010-0726-2","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T01:00:53Z","timestamp":1291078853000},"page":"697-701","source":"Crossref","is-referenced-by-count":41,"title":["Treatment of advanced extranodal NK\/T cell lymphoma, nasal-type and aggressive NK-cell leukemia"],"prefix":"10.1007","volume":"92","author":[{"given":"Ritsuro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,1]]},"reference":[{"key":"726_CR1","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V87.4.1207.bloodjournal8741207","volume":"87","author":"ES Jaffe","year":"1996","unstructured":"Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood. 1996;87:1207\u201310.","journal-title":"Blood"},{"key":"726_CR2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02983235","volume":"78","author":"K Oshimi","year":"2003","unstructured":"Oshimi K. Leukemia and lymphoma of natural killer lineage cells. Int J Hematol. 2003;78:18\u201323.","journal-title":"Int J Hematol"},{"key":"726_CR3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hon.847","volume":"26","author":"R Suzuki","year":"2008","unstructured":"Suzuki R, Takeuchi K, Ohshima K, Nakamura S. Extranodal NK\/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol. 2008;26:66\u201372.","journal-title":"Hematol Oncol"},{"key":"726_CR4","first-page":"285","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Quintanilla-Martinez L, Ferry JA. Peh S-C. Extranodal NK\/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 285\u20138."},{"key":"726_CR5","first-page":"276","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Jaffe ES, Ralfkiaer E, Ko Y-H. Aggressive NK-cell leukemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2008. p. 276\u20137."},{"key":"726_CR6","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","volume":"76","author":"M Yamaguchi","year":"1995","unstructured":"Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T, et al. Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells. Cancer. 1995;76:2351\u20136.","journal-title":"Cancer"},{"key":"726_CR7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","volume":"93","author":"M Egashira","year":"1999","unstructured":"Egashira M, Kawamata N, Sugimoto K, Oshimi K. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood. 1999;93:599\u2013606.","journal-title":"Blood"},{"key":"726_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2141.2001.02885.x","volume":"114","author":"C Trambas","year":"2001","unstructured":"Trambas C, Wang Z, Cianfriglia M, Woods G. Evidence that natural killer cells express mini P-glycoproteins but not classic 170\u00a0kDa P-glycoprotein. Br J Haematol. 2001;114:177\u201384.","journal-title":"Br J Haematol"},{"key":"726_CR9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","volume":"328","author":"RI Fisher","year":"1993","unstructured":"Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;328:1002\u20136.","journal-title":"N Engl J Med"},{"key":"726_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02983387","volume":"78","author":"W Yong","year":"2003","unstructured":"Yong W, Zheng W, Zhang Y, Zhu J, Wei Y, Zhu D, Li J. l-asparaginase-based regimen in the treatment of refractory midline nasal\/nasal-type T\/NK-cell lymphoma. Int J Hematol. 2003;78:163\u20137.","journal-title":"Int J Hematol"},{"key":"726_CR11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1349-7006.2008.00768.x","volume":"99","author":"M Yamaguchi","year":"2008","unstructured":"Yamaguchi M, Suzuki R, Kwong YL, Kim WS, Hasegawa Y, Izutsu K, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia. Cancer Sci. 2008;99:1016\u201320.","journal-title":"Cancer Sci"},{"key":"726_CR12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdn542","volume":"20","author":"A Jaccard","year":"2009","unstructured":"Jaccard A, Petit B, Girault S, Suarez F, Gressin R, Zini JM, et al. l-Asparaginase-based treatment of 15 western patients with extranodal NK\/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol. 2009;20:110\u20136.","journal-title":"Ann Oncol"},{"key":"726_CR13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the international prognostic index. Blood. 2004;103:216\u201321.","journal-title":"Blood"},{"key":"726_CR14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol. 2006;24:612\u20138.","journal-title":"J Clin Oncol"},{"key":"726_CR15","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","volume":"21","author":"R Suzuki","year":"2010","unstructured":"Suzuki R, Suzumiya J, Yamaguchi M, Nakamura S, Kameoka J, Kojima H, et al. Prognostic factors for mature natural killer (NK)-cell neoplasms: aggressive NK-cell leukemia and extranodal NK-cell lymphoma, nasal-type. Ann Oncol. 2010;21:1032\u201340.","journal-title":"Ann Oncol"},{"key":"726_CR16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.1995.13.3.666","volume":"13","author":"R Liang","year":"1995","unstructured":"Liang R, Todd D, Chan TK, Chiu E, Lie A, Kwong YL, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 1995;13:666\u201370.","journal-title":"J Clin Oncol"},{"key":"726_CR17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","volume":"16","author":"MMC Cheung","year":"1998","unstructured":"Cheung MMC, Chan JKC, Lau WH, Foo W, Chan PT, Ng CS, et al. Primary non-Hodgkin\u2019s lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70\u20137.","journal-title":"J Clin Oncol"},{"key":"726_CR18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<449::AID-CNCR13>3.0.CO;2-W","volume":"83","author":"YX Li","year":"1998","unstructured":"Li YX, Coucke PA, Li JY, Gu DZ, Liu XF, Zhou LQ, et al. Primary non-Hodgkin\u2019s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer. 1998;83:449\u201356.","journal-title":"Cancer"},{"key":"726_CR19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02983236","volume":"78","author":"K Kawa","year":"2003","unstructured":"Kawa K. Diagnosis and treatment of Epstein\u2013Barr virus-associated natural killer cell lymphoproliferative disease. Int J Hematol. 2003;78:24\u201331.","journal-title":"Int J Hematol"},{"key":"726_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3960\/jslrt.45.51","volume":"45","author":"R Suzuki","year":"2005","unstructured":"Suzuki R. Leukemia and lymphoma of natural killer cells. J Clin Exp Hematop. 2005;45:51\u201370.","journal-title":"J Clin Exp Hematop"},{"key":"726_CR21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02982090","volume":"74","author":"K Nagafuji","year":"2001","unstructured":"Nagafuji K, Fujisaki T, Arima F, Ohshima K. l-Asparaginase induced durable remission of relapsed nasal NK\/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol. 2001;74:447\u201350.","journal-title":"Int J Hematol"},{"key":"726_CR22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02983802","volume":"78","author":"K Obama","year":"2003","unstructured":"Obama K, Tara M, Niina K. l-Asparaginase-based induction therapy for advanced extranodal NK\/T-cell lymphoma. Int J Hematol. 2003;78:248\u201350.","journal-title":"Int J Hematol"},{"key":"726_CR23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/1042819031000067873","volume":"44","author":"Y Matsumoto","year":"2003","unstructured":"Matsumoto Y, Nomura K, Kanda-Akano Y, Fujita Y, Nakao M, Ueda K, et al. Successful treatment with Erwinia l-asparaginase for recurrent natural killer\/T cell lymphoma. Leuk Lymphoma. 2003;44:879\u201382.","journal-title":"Leuk Lymphoma"},{"key":"726_CR24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2141.2005.05694.x","volume":"130","author":"M Ando","year":"2005","unstructured":"Ando M, Sugimoto K, Kitoh T, Sasaki M, Mukai K, Ando J, et al. Selective apoptosis of natural killer-cell tumours by l-asparaginase. Br J Haematol. 2005;130:860\u20138.","journal-title":"Br J Haematol"},{"key":"726_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.2004.04863.x","volume":"125","author":"JP Pinheiro","year":"2004","unstructured":"Pinheiro JP, Boos J. The best way to use asparaginase in childhood acute lymphatic leukaemia\u2014still to be defined? Br J Haematol. 2004;125:117\u201327.","journal-title":"Br J Haematol"},{"key":"726_CR26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166\u201378.","journal-title":"N Engl J Med"},{"key":"726_CR27","doi-asserted-by":"crossref","unstructured":"Jaccard A, Gachard N, Coppo P, Morschhauser F, Galicier L, Ysebaert L, et al. A prospective phase II trial of an l-Asparaginase containing regimen in patients with refractory or relapsing extranodal NK\/T-cell lymphoma. Blood 2008; 112:217a (Abstract #579).","DOI":"10.1182\/blood.V112.11.579.579"},{"key":"726_CR28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s007760050098","volume":"4","author":"Y Yazawa","year":"1999","unstructured":"Yazawa Y, Takagi T, Asakura S, Suzuki K, Kano Y. Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines. J Orthop Sci. 1999;4:231\u20137.","journal-title":"J Orthop Sci"},{"key":"726_CR29","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.leu.2402573","volume":"16","author":"M Akutsu","year":"2002","unstructured":"Akutsu M, Furukawa Y, Tsunoda S, Izumi T, Ohmine K, Kano Y. Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro. Leukemia. 2002;16:1808\u201317.","journal-title":"Leukemia."},{"key":"726_CR30","doi-asserted-by":"crossref","unstructured":"Yamaguchi M, Kwong Y, Maeda Y, Hashimoto C, Kim W, Suh C, et al. Phase II study of SMILE chemotherapy for newly-diagnosed stage IV, relapsed or refractory extranodal NK\/T-cell lymphoma, nasal type: NKTSG study. J Clin Oncol 2010; 28:584s (Abstract #8044).","DOI":"10.1200\/jco.2010.28.15_suppl.8044"},{"key":"726_CR31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","volume":"18","author":"R Suzuki","year":"2004","unstructured":"Suzuki R, Suzumiya J, Nakamura S, Aoki S, Notoya A, Ozaki S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia. 2004;18:763\u201370.","journal-title":"Leukemia"},{"key":"726_CR32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","volume":"44","author":"Y Nakashima","year":"2005","unstructured":"Nakashima Y, Tagawa H, Suzuki R, Karnan S, Karube K, Ohshima K, et al. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: Different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK\/T-cell lymphoma, nasal type. Genes Chromosomes Cancer. 2005;44:247\u201355.","journal-title":"Genes Chromosomes Cancer"},{"key":"726_CR33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-065X.2006.00451.x","volume":"214","author":"AG Freud","year":"2006","unstructured":"Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev. 2006;214:56\u201372.","journal-title":"Immunol Rev"},{"key":"726_CR34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri MA. Human natural killer cells. Blood. 2008;112:461\u20139.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0726-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0726-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0726-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T05:28:20Z","timestamp":1592112500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0726-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["726"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0726-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}